Literature DB >> 9915445

Radical cystoprostatectomy: an extraperitoneal retrograde approach.

J N Kulkarni1, R I Gulla, H B Tongaonkar, B D Kashyapi, K B Rajyaguru.   

Abstract

PURPOSE: We describe a new technical approach for the surgical management of bladder cancer.
MATERIALS AND METHODS: Patients with invasive bladder cancer underwent radical cystoprostatectomy using a technically different approach than the conventional method. The important features of this modification include a small infraumbilical incision, completely extraperitoneal dissection to maintain the bowel loops away from the operating field, urethral dissection performed earlier in the operation rather than at the end to preserve the striated urethral sphincter with the neurovascular bundles, completely retrograde dissection of the rectovesical plane for increased safety and reperitonealization done at completion to isolate the urinary anastomoses from the bowel anastomosis.
RESULTS: More than 50 consecutive patients with early bladder cancer underwent this operation during a 2-year period. The technique was safe and satisfactory.
CONCLUSIONS: Radical retrograde extraperitoneal cystoprostatectomy is based on a finer knowledge of anatomy. It requires accurate dissection, making it inherently superior to the conventional method.

Entities:  

Mesh:

Year:  1999        PMID: 9915445     DOI: 10.1016/s0022-5347(01)61946-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Extraperitoneal radical cystectomy with extraperitonealization of the ileal neobladder: a comparison to the transperitoneal technique.

Authors:  Florian Jentzmik; Martin Schostak; Carsten Stephan; Daniel Baumunk; Anja Lingnau; Steffen Weikert; Michael Lein; Kurt Miller; Mark Schrader
Journal:  World J Urol       Date:  2009-09-24       Impact factor: 4.226

2.  Technical steps of open radical cystectomy and orthotopic neobladder to achieve the goals of "minimally invasive surgery"?

Authors:  Anil Mandhani; Anand Dharaskar; Rakesh Kapoor
Journal:  Indian J Urol       Date:  2010-07

3.  Retropubic radical prostatectomy: Clinicopathological observations and outcome analysis of 428 consecutive patients.

Authors:  Jagdeesh N Kulkarni; Dayal Partap Singh; Shweta Bansal; Manisha Makkar; Rohan Valsangkar; Avinash T Siddaiah; Pushkar Sham Choudhary
Journal:  Indian J Urol       Date:  2011-07

4.  Perioperative morbidity of radical cystectomy: A review.

Authors:  Jagdeesh N Kulkarni
Journal:  Indian J Urol       Date:  2011-04

5.  Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study.

Authors:  Xiaojian Qin; Hailiang Zhang; Fangning Wan; Yiping Zhu; Yijun Shen; Bo Dai; Guohai Shi; Yao Zhu; Dingwei Ye
Journal:  World J Surg Oncol       Date:  2015-03-31       Impact factor: 2.754

6.  Extraperitoneal laparoscopic radical cystectomy with intracorporeal neobladder: a comparison with transperitoneal approach.

Authors:  Ying Zhang; Huan Zhou; Zhou Ting Tuo; Jinyou Wang; Chenyu Sun; Liangkuan Bi
Journal:  World J Surg Oncol       Date:  2022-04-23       Impact factor: 3.253

7.  Laparoscopic radical cystectomy with pelvic lymph node dissection and ileal orthotopic neobladder by a total extraperitoneal approach: Our initial technique and short-term outcomes.

Authors:  Guanqun Zhu; Zongliang Zhang; Kai Zhao; Xinbao Yin; Yulian Zhang; Zhenlin Wang; Chen Li; Yuanming Sui; Xueyu Li; Han Yang; Nianzeng Xing; Ke Wang
Journal:  Investig Clin Urol       Date:  2022-09

8.  Extraperitoneal versus transperitoneal laparoscopic radical cystectomy for selected elderly bladder cancer patients: a single center experience.

Authors:  Lang Feng; Jian Song; Menghua Wu; Ye Tian; Daoxin Zhang
Journal:  Int Braz J Urol       Date:  2016 Jul-Aug       Impact factor: 1.541

9.  Transperitoneal vs. extraperitoneal radical cystectomy for bladder cancer: A retrospective study.

Authors:  Jagdeesh N Kulkarni; Himanshu Agarwal
Journal:  Int Braz J Urol       Date:  2018 Mar-Apr       Impact factor: 1.541

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.